Edgewise Therapeutics (EWTX)

• Market cap: $1.92B
• 1 day: -8.50%
• 5 days: -11.52%
• 1 month: -21.15%
• 3 months: -25.53%
• 6 months: -26.29%
• Year to date: -25.53%
• 1 year: 11.71%
• 5 years: -32.90%
• 10 years: -32.90%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

137% more call options, than puts

Call options by funds: $23.3M | Put options by funds: $9.82M

125% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 20

13% more funds holding

Funds holding: 175 [Q3] → 198 (+23) [Q4]

13% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 62

13% more funds holding in top 10

Funds holding in top 10: 8 [Q3] → 9 (+1) [Q4]

3% less capital invested

Capital invested by funds: $2.71B [Q3] → $2.64B (-$68.2M) [Q4]

3.75% less ownership

Funds ownership: 108.28% [Q3] → 104.53% (-3.75%) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $30 49% upside
• Avg. target: $45 125% upside
• High target: $56 178% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

Scotiabank Louise Chen 35% 1-year accuracy 46 / 133 met price target	148% upside $50	Sector Outperform Initiated	7 Mar 2025
RBC Capital Leonid Timashev 31% 1-year accuracy 13 / 42 met price target	178% upside $56	Outperform Reiterated	4 Mar 2025
Stifel James Condulis 67% 1-year accuracy 2 / 3 met price target	49% upside $30	Hold Initiated	22 Jan 2025